Improving oncology outcomes through targeted therapeutics will require electronic delivery systems

Area of Science:

• Genomic medicine
• Clinical informatics
• Personalized oncology

Background:

• Chemotherapy selection traditionally relies on patient demographics, symptoms, and history.
• Genomics tests for targeted therapeutics are available but face challenges in clinical data integration.
• Processing genomic data within patient context for timely, interpretable dosing guidance is a significant hurdle.

Purpose of the Study:

• To address the challenge of integrating genomic data into clinical decision-making for chemotherapy.
• To explore the role of clinical decision support systems in delivering personalized medicine.
• To facilitate the adoption of electronic health record systems through enhanced point-of-care information delivery.

Main Methods:

• Utilizing clinical decision support systems (CDSS) integrated with electronic health records (EHR).
• Developing methods to process genomic data within the patient's specific context.
• Focusing on generating clinically interpretable dosing guidance for physicians.

Main Results:

• CDSS connected to EHRs can provide personalized information at the point-of-care.
• This integration can improve the acceptance and adaptation of EHR systems.
• The workflow can be enhanced by providing actionable genomic insights during routine patient care.

Conclusions:

• Realizing the potential of targeted therapeutics requires overcoming political, ethical, socioeconomic, and technical challenges.
• Concerted stakeholder efforts are crucial for the widespread adoption of personalized medicine.
• Successful implementation hinges on integrating genomic data effectively into clinical workflows.